Resistance to broad-spectrum antibiotics is a major evolving problem in clinical practice. Pereira et al. (1) are to be commended for publishing a retrospective study highlighting risk factors for carbapenemresistant enterobacteriaceae (CRE) infection in liver transplantation (LT) recipients. The authors reported a major adverse impact of CRE infections on post-LT survival, with a 1-year estimated survival of 55% for LT recipients with CRE infection compared to 93% for noninfected controls (hazard ratio, 8.4; 95% confidence interval, 4.0-17.3; P < 0.001).Outbreaks of CRE infection following endoscopic retrograde cholangiopancreatography (ERCP) have been a major theme of public health interest in the recent past and have been largely attributed to complexities in achieving adequate cleaning of specific parts of duodenoscopes. These outbreaks resulted in issuance of new equipment reprocessing guidelines by the Food and Drug Administration. The actual incidence of ERCP-related CRE infections remains largely unknown; nevertheless, LT recipients epitomize a population at significant risk for several reasons. Patients with end-stage liver disease accumulate risk factors for colonization with drug-resistant organisms due to numerous hospitalizations, invasive procedures, and frequent use of antibiotics. Biliary complications are important causes of morbidity and mortality after LT with an overall incidence of 5%-25%, and ERCP remains the therapeutic modality of choice in the majority of cases. (2) It has been estimated that more than 500,000 ERCPs are performed annually in the United States, (3) and data from a single-center study show that approximately 6% of ERCPs over 11.5 years were performed in LT recipients. (4) Specifically related to ERCP for treatment of biliary complications following LT, bactobilia with enterobacterial isolates has been reported in up to 47% of LT recipients undergoing this procedure and results in diminished survival. (5) Therefore, ERCP represents an important source for infection in this at-risk population. Although Pereira et al. (1) found no association between ERCPs performed before or after LT and CRE infection, the number of studied patients (304) was small and this study should not provide reassurance in this particular matter. In light of recent outbreaks, LT teams should remain vigilant for this infection in patients undergoing this important therapeutic intervention.